Lymphadenectomy Does Not Up Survival in Advanced Ovarian Cancer

Share this content:
Lymphadenectomy Does Not Up Survival in Advanced Ovarian Cancer
Lymphadenectomy Does Not Up Survival in Advanced Ovarian Cancer

WEDNESDAY, Feb. 27, 2019 (HealthDay News) -- For patients with advanced ovarian cancer who have undergone intra-abdominal macroscopically complete resection and have clinically negative lymph nodes, lymphadenectomy is not associated with longer overall or progression-free survival, according to a study published in the Feb. 28 issue of the New England Journal of Medicine.

Philipp Harter, M.D., Ph.D., from Charité-Universitätsmedizin Berlin, and colleagues intraoperatively randomly assigned patients with newly diagnosed advanced ovarian cancer who had undergone macroscopically complete resection and had normal lymph nodes before and during surgery to undergo (323 patients) or not undergo lymphadenectomy (324 patients).

The researchers found that the median number of removed nodes was 57 among patients who underwent lymphadenectomy (35 pelvic and 22 para-aortic nodes). Median overall survival was 69.2 and 65.5 months in the no-lymphadenectomy and lymphadenectomy groups, respectively (hazard ratio for death, 1.06; 95 percent confidence interval, 0.83 to 1.34; P = 0.65); in both groups, median progression-free survival was 25.5 months (hazard ratio, 1.11; 95 percent confidence interval, 0.92 to 1.34; P = 0.29). The lymphadenectomy group more often had serious postoperative complications, including incidence of repeat laparotomy (12.4 versus 6.5 percent; P = 0.01) and mortality within 60 days after surgery (3.1 versus 0.9 percent; P = 0.049).

"The results of this prospectively randomized, adequately powered, international, multicenter trial add level 1 evidence to the long-standing discussion about the role of lymphadenectomy in advanced ovarian cancer," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »